High-volume hemofiltration combined with early-goal-directed therapy improves alveolar-arterial oxygen exchange in patients with refractory septic shock

This study is to evaluate the effect of high-volume hemofiltration (HVHF) and early-goal-directed therapy (EGDT) on alveolar-arterial oxygen exchange in patients with refractory septic shock. Patients were classified into two groups by a prospective cohort study: 86 received both HVHF and EGDT (the HVHF group), and 81 treated with EGDT only (the control group). Alveolar-arterial oxygen pressure was taken at baseline and at days 1, 3, and 7, and respiratory index (RI, ratio of P_aO₂ alveolar-arterial oxygen pressure difference (P_A-aDO₂) to arterial oxygen pressure (P_aO₂)) was calculated. Results showed that at day 7, the levels of central venous and arterial blood oxygen content were significantly higher in the HVHF vs. the control group (both with p < 0.05). The level of oxygen extraction ratio (O₂ER) was significantly higher in the HVHF than the control group (p < 0.01). The levels of P_A-aDO₂ and RI were significantly lower in the HVHF than the control group (p < 0.05 and p < 0.01, respectively). RI and the ratio of P_aO₂ to fraction of inspired oxygen were significantly higher in the HVHF than the control group (p < 0.05 and p < 0.01, respectively). The acute physiology and chronic health evaluation score and the sequential organ failure assessment score in the HVHF group were significantly lower compared to the control group (p < 0.01 and p < 0.05, respectively). At day 28, the mortality rate was lower in the HVHF vs. the control group (p < 0.01).

These findings demonstrated that HVHF, when used as an adjunctive therapy to the EGDP protocol, could improve alveolar-arterial oxygen exchange, clinical outcome and survival in patients with refractory septic shock.

L'articolo High-volume hemofiltration combined with early-goal-directed therapy improves alveolar-arterial oxygen exchange in patients with refractory septic shock sembra essere il primo su European Review.

from #Medicine via ola Kala on Inoreader http://ift.tt/1mumiJO
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1QyJEuw
via IFTTT